Delivery Order SPE2DB22D3301-SPE2DB25FZ1ME
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,392.59 to AmerisourceBergen Drug Corp for Lamotrigine ER 100 mg tablets (30-count supply) on August 26, 2025, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lamotrigine ER 300 mg tablets in quantities of 30 units. This contract is valued at $1,704.06 with a firm fixed price structure and a completion date of August 26, 2025. The order represents a non-competitive, non-set-aside delivery under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.23 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used to treat epilepsy and bipolar...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Lamotrigine ER 200 mg tablets in 30-count quantities. This contract, valued at $1,133.76, represents a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.28 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price, competitively awarded delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lamotrigine ER 300 mg tablets (30-count units) with a ceiling value of $1,331.43. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on September 11, 2025, with performance to be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 200 mg tablets (30-count units) on August 26, 2025, with a ceiling value of $1,004.61. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date for this delivery order is August 27,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lamotrigine ER 200 mg tablets in a 30-count package, with a ceiling value of $1,516.80 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle valued through December 2026 that provides...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets in quantities of 30 units, with a ceiling value of $4,276.80. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the place of performance for this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,323.38 to AmerisourceBergen Drug Corp for Lamotrigine ER 200 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Lamotrigine is a generic anticonvulsant and mood-stabilizing medication commonly used in military...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1MEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,426.01 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count) on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that functions as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Through its extensive portfolio of federal contract awards, the company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent IDC with DLA Troop Support Medical encompasses critical medical commodities including specialty medications, vaccines, syringes, vials, and test kits, enabling AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/24/25 |